Origin, a 3D printing specialist for medical devices, completed clinical trials and validation of the company’s 3D-printed nasopharyngeal swabs for use in COVID-19 test kits.
https://www.pharmalive.com/wp-content/uploads/2020/04/Origin-Ramps-Up-Production-of-3D-Printed-Test-Swabs-BioSpace-4-14-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-04-14 11:25:362020-04-14 23:08:13Origin Ramps Up Production of 3D-Printed Test Swabs